Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

608 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Structurally engineered highly efficient electrocatalytic performance of 3-dimensional Mo/Ni chalcogenides for boosting overall water splitting performance.
Mahadik S, Surendran S, Moon DJ, Kim JY, Janani G, Jesudass SC, Veeramani K, Choi H, Shanmugapriya S, Kim IG, Jung P, Park YI, Heo J, Kim TH, Hong K, Sim U. Mahadik S, et al. Among authors: jung p. Chemosphere. 2024 Mar;352:141233. doi: 10.1016/j.chemosphere.2024.141233. Epub 2024 Jan 22. Chemosphere. 2024. PMID: 38266882
Defect engineered ternary metal spinel-type Ni-Fe-Co oxide as bifunctional electrocatalyst for overall electrochemical water splitting.
Jesudass SC, Surendran S, Moon DJ, Shanmugapriya S, Kim JY, Janani G, Veeramani K, Mahadik S, Kim IG, Jung P, Kwon G, Jin K, Kim JK, Hong K, Park YI, Kim TH, Heo J, Sim U. Jesudass SC, et al. Among authors: jung p. J Colloid Interface Sci. 2024 Jun;663:566-576. doi: 10.1016/j.jcis.2024.02.042. Epub 2024 Feb 7. J Colloid Interface Sci. 2024. PMID: 38428114
Discovery and Characterization of Brigimadlin, a Novel and Highly Potent MDM2-p53 Antagonist Suitable for Intermittent Dose Schedules.
Gollner A, Rudolph D, Weyer-Czernilofsky U, Baumgartinger R, Jung P, Weinstabl H, Ramharter J, Grempler R, Quant J, Rinnenthal J, Pérez Pitarch A, Golubovic B, Gerlach D, Bader G, Wetzel K, Otto S, Mandl C, Boehmelt G, McConnell DB, Kraut N, Sini P. Gollner A, et al. Among authors: jung p. Mol Cancer Ther. 2024 Sep 11. doi: 10.1158/1535-7163.MCT-23-0783. Online ahead of print. Mol Cancer Ther. 2024. PMID: 39259562
Utilization and consequences of CRP point-of-care-testing in primary care practices: a real-world multicentre observational study with 1,740 patient cases in Germany.
Markwart R, Lehmann LS, Krause M, Jung P, Rost L, Doepfmer S, Kuempel L, Kuschick D, Toutaoui KJ, Heintze C, Bleidorn J, Wolf F. Markwart R, et al. Among authors: jung p. BJGP Open. 2024 Aug 19:BJGPO.2024.0120. doi: 10.3399/BJGPO.2024.0120. Online ahead of print. BJGP Open. 2024. PMID: 39159989 Free article.
608 results